Matches in Wikidata for { <http://www.wikidata.org/entity/Q92958135> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q92958135 description "2019 թվականի հունիսի 12-ին հրատարակված գիտական հոդված" @default.
- Q92958135 description "article scientifique publié en 2019" @default.
- Q92958135 description "artículu científicu espublizáu en xunu de 2019" @default.
- Q92958135 description "im Juni 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92958135 description "scientific article published on 12 June 2019" @default.
- Q92958135 description "wetenschappelijk artikel" @default.
- Q92958135 description "наукова стаття, опублікована 12 червня 2019" @default.
- Q92958135 name "Characteristics of trials and regulatory pathways leading to US approval of innovative vs. non-innovative oncology drugs" @default.
- Q92958135 name "Characteristics of trials and regulatory pathways leading to US approval of innovative vs. non-innovative oncology drugs" @default.
- Q92958135 type Item @default.
- Q92958135 label "Characteristics of trials and regulatory pathways leading to US approval of innovative vs. non-innovative oncology drugs" @default.
- Q92958135 label "Characteristics of trials and regulatory pathways leading to US approval of innovative vs. non-innovative oncology drugs" @default.
- Q92958135 prefLabel "Characteristics of trials and regulatory pathways leading to US approval of innovative vs. non-innovative oncology drugs" @default.
- Q92958135 prefLabel "Characteristics of trials and regulatory pathways leading to US approval of innovative vs. non-innovative oncology drugs" @default.
- Q92958135 P1433 Q92958135-3AE9BE3B-C1AE-4AC5-A805-6D6B0D2B46D7 @default.
- Q92958135 P1476 Q92958135-6C6CD6A0-F2AC-491B-9D20-19D299F11BFD @default.
- Q92958135 P2093 Q92958135-30753CBD-9372-4760-AA05-574E9D549F0E @default.
- Q92958135 P304 Q92958135-4D470E33-C053-497E-BB5D-AE7BB75D9AC4 @default.
- Q92958135 P31 Q92958135-811D7D8B-DFC6-4E66-A6EA-3654DA63F955 @default.
- Q92958135 P356 Q92958135-B730C2F9-A4EF-4E61-9F08-633D07552968 @default.
- Q92958135 P433 Q92958135-E333BBE5-2363-42A3-946F-73BF5C47C486 @default.
- Q92958135 P478 Q92958135-F8169158-A144-4599-B309-E5C88E0A134F @default.
- Q92958135 P50 Q92958135-40A2D8C6-1471-49DF-9B4E-8C713C15A808 @default.
- Q92958135 P577 Q92958135-CA36C643-B43F-4AA8-B5DC-80759C66122B @default.
- Q92958135 P698 Q92958135-787B0E9D-44BA-4795-BAEA-4D25E58E7AAA @default.
- Q92958135 P356 J.HEALTHPOL.2019.06.002 @default.
- Q92958135 P698 31229275 @default.
- Q92958135 P1433 Q15758180 @default.
- Q92958135 P1476 "Characteristics of trials and regulatory pathways leading to US approval of innovative vs. non-innovative oncology drugs" @default.
- Q92958135 P2093 "Kerstin Noëlle Vokinger" @default.
- Q92958135 P304 "721-727" @default.
- Q92958135 P31 Q13442814 @default.
- Q92958135 P356 "10.1016/J.HEALTHPOL.2019.06.002" @default.
- Q92958135 P433 "8" @default.
- Q92958135 P478 "123" @default.
- Q92958135 P50 Q50786389 @default.
- Q92958135 P577 "2019-06-12T00:00:00Z" @default.
- Q92958135 P698 "31229275" @default.